EXHIBIT 11. STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
(Unaudited)
Eli Lilly and Company and Subsidiaries
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2008 | 2007 | 2008 | 2007 | |||||||||||||
| (Dollars and shares in millions except per-share data) | ||||||||||||||||
BASIC |
||||||||||||||||
Net income (loss) |
$ | (465.6 | ) | $ | 926.3 | $ | 1,557.5 | $ | 2,098.6 | |||||||
Average number of common shares outstanding |
1,092.2 | 1,089.1 | 1,091.9 | 1,088.8 | ||||||||||||
Contingently issuable shares |
1.8 | 1.0 | 2.0 | 1.0 | ||||||||||||
Adjusted average shares |
1,094.0 | 1,090.1 | 1,093.9 | 1,089.8 | ||||||||||||
Basic earnings (loss) per share |
$ | (.43 | ) | $ | .85 | $ | 1.42 | $ | 1.93 | |||||||
DILUTED |
||||||||||||||||
Net income (loss) |
$ | (465.6 | ) | $ | 926.3 | $ | 1,557.5 | $ | 2,098.6 | |||||||
Average number of common shares outstanding |
1,092.2 | 1,089.1 | 1,091.9 | 1,088.8 | ||||||||||||
Incremental shares — stock options and
contingently issuable shares |
1.8 | 1.1 | 2.0 | 1.3 | ||||||||||||
Adjusted average shares |
1,094.0 | 1,090.2 | 1,093.9 | 1,090.1 | ||||||||||||
Diluted earnings (loss) per share |
$ | (.43 | ) | $ | .85 | $ | 1.42 | $ | 1.93 | |||||||